Compounds > inogatran
Page last updated: 2024-08-24

inogatran and Blood Clot

inogatran has been researched along with Blood Clot in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Mattsson, C; Mehta, JL; Nichols, WW; Saldeen, TG; Teger-Nilsson, AC1
Börjesson, I; Elg, M; Gustafsson, D; Lenfors, S; Teger-Nilsson, AC1
Deschenes, I; DiMaio, J; Finkle, CD; Leblond, L; St Pierre, A; Winocour, PD1
Bousley, RF; Chi, L; Gallagher, KP; Janiczek, N; Juneau, PL; Mertz, TE; Peng, YW; Rogers, KL; Saganek, L; Uprichard, AC1

Other Studies

4 other study(ies) available for inogatran and Blood Clot

ArticleYear
Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:3

    Topics: Animals; Dogs; Female; Glycine; Hemodynamics; Male; Molecular Weight; Piperidines; Thrombin; Thrombosis; Tissue Plasminogen Activator

1996
Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:1

    Topics: Animals; Antithrombins; Arginine; Aspirin; Bleeding Time; Disease Models, Animal; Fibrinolytic Agents; Glycine; Heparin; Male; Molecular Weight; Pipecolic Acids; Piperidines; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombolytic Therapy; Thrombophlebitis; Thrombosis

1996
BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:2

    Topics: Animals; Anticoagulants; Arginine; Arteries; Glycine; Heparin; Hirudins; Humans; Infusions, Intravenous; Oligopeptides; Peptide Fragments; Pipecolic Acids; Piperidines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Veins

1998
Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran.
    Journal of thrombosis and thrombolysis, 2001, Volume: 11, Issue:1

    Topics: Animals; Benzamides; Bleeding Time; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycine; Hemostasis; Implants, Experimental; Injections; Piperidines; Rabbits; Regional Blood Flow; Thrombin; Thrombosis; Vena Cava, Superior

2001